Loading...

EXEL EXELIXIS INC Management Changes 8-K Filing

XLXS

XL

EXELIXIS INC

(EXEL)

2025 8-K

Management Changes

Stock Buyback Announcement

Management Changes

Financial Statements

Financial Statements

Stock Award Program

Financial Results

Financial Results

Financial Results

Clinical Collaboration

Financial Results and Stock...

Annual Meeting Approval

Settlement and License Agre...

Complaint filed against Cip...

Financial Results Announcement

Departure of Directors

Financial Results Announcement

Earnings Release, Restructu...

Amendments to Change in Con...

Financial Results Announcement

Departure of Directors

Departure of Directors

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Resignation of Director

Departure of Directors

External Links:

On August 29, 2025, Exelixis, Inc. appointed Dana T. Aftab as Executive Vice President, Research and Development, while Amy C. Peterson stepped down as Chief Medical Officer, receiving severance payments as per the company's policy.

AI Assistant

EXELIXIS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.